251 related articles for article (PubMed ID: 33512451)
21. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
22. Peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells (CLPD-NK): a case report and literature review.
An H; Guo J; Guo H; Hu W; Lu M
BMC Neurol; 2023 Sep; 23(1):314. PubMed ID: 37658347
[TBL] [Abstract][Full Text] [Related]
23. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
[TBL] [Abstract][Full Text] [Related]
24. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
Qiu ZY; Fan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
[TBL] [Abstract][Full Text] [Related]
25. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
[TBL] [Abstract][Full Text] [Related]
26. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy.
López-Nevado M; Ortiz-Martín J; Serrano C; Pérez-Saez MA; López-Lorenzo JL; Gil-Etayo FJ; Rodríguez-Frías E; Cabrera-Marante O; Morales-Pérez P; Rodríguez-Pinilla MS; Manso R; Salgado-Sánchez RN; Cerdá-Montagud A; Quesada-Espinosa JF; Gómez-Rodríguez MJ; Paz-Artal E; Muñoz-Calleja C; Arranz-Sáez R; Allende LM
J Clin Immunol; 2023 Jan; 43(1):165-180. PubMed ID: 36066697
[TBL] [Abstract][Full Text] [Related]
27. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
29. Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.
Tanahashi T; Sekiguchi N; Matsuda K; Takezawa Y; Ito T; Kobayashi H; Ichikawa N; Nishina S; Senoo N; Sakai H; Nakazawa H; Ishida F
Leuk Res; 2016 Jun; 45():8-13. PubMed ID: 27064362
[TBL] [Abstract][Full Text] [Related]
30. Germline TET2 loss of function causes childhood immunodeficiency and lymphoma.
Stremenova Spegarova J; Lawless D; Mohamad SMB; Engelhardt KR; Doody G; Shrimpton J; Rensing-Ehl A; Ehl S; Rieux-Laucat F; Cargo C; Griffin H; Mikulasova A; Acres M; Morgan NV; Poulter JA; Sheridan EG; Chetcuti P; O'Riordan S; Anwar R; Carter CR; Przyborski S; Windebank K; Cant AJ; Lako M; Bacon CM; Savic S; Hambleton S
Blood; 2020 Aug; 136(9):1055-1066. PubMed ID: 32518946
[TBL] [Abstract][Full Text] [Related]
31. Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?
Giussani E; Binatti A; Calabretto G; Gasparini VR; Teramo A; Vicenzetto C; Barilà G; Facco M; Coppe A; Semenzato G; Bortoluzzi S; Zambello R
Front Oncol; 2020; 10():613570. PubMed ID: 33585237
[TBL] [Abstract][Full Text] [Related]
32. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
33. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells.
Pan F; Wingo TS; Zhao Z; Gao R; Makishima H; Qu G; Lin L; Yu M; Ortega JR; Wang J; Nazha A; Chen L; Yao B; Liu C; Chen S; Weeks O; Ni H; Phillips BL; Huang S; Wang J; He C; Li GM; Radivoyevitch T; Aifantis I; Maciejewski JP; Yang FC; Jin P; Xu M
Nat Commun; 2017 Apr; 8():15102. PubMed ID: 28440315
[TBL] [Abstract][Full Text] [Related]
34. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
35. Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients.
Hoshida Y; Hongyo T; Nakatsuka S; Nishiu M; Takakuwa T; Tomita Y; Nomura T; Aozasa K
Lab Invest; 2002 Mar; 82(3):257-64. PubMed ID: 11896204
[TBL] [Abstract][Full Text] [Related]
36. Next-generation sequencing technology a new tool for killer cell immunoglobulin-like receptor allele typing in hematopoietic stem cell transplantation.
Maniangou B; Retière C; Gagne K
Transfus Clin Biol; 2018 Feb; 25(1):87-89. PubMed ID: 29032017
[TBL] [Abstract][Full Text] [Related]
37. Toward a Better Classification System for NK-LGL Disorders.
Drillet G; Pastoret C; Moignet A; Lamy T; Marchand T
Front Oncol; 2022; 12():821382. PubMed ID: 35178350
[TBL] [Abstract][Full Text] [Related]
38. CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.
Baer C; Kimura S; Rana MS; Kleist AB; Flerlage T; Feith DJ; Chockley P; Walter W; Meggendorfer M; Olson TL; Cheon H; Olson KC; Ratan A; Mueller ML; Foran JM; Janke LJ; Qu C; Porter SN; Pruett-Miller SM; Kalathur RC; Haferlach C; Kern W; Paietta E; Thomas PG; Babu MM; Loughran TP; Iacobucci I; Haferlach T; Mullighan CG
Nat Genet; 2022 May; 54(5):637-648. PubMed ID: 35513723
[TBL] [Abstract][Full Text] [Related]
39. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.
Huang L; Liu D; Wang N; Ling S; Tang Y; Wu J; Hao L; Luo H; Hu X; Sheng L; Zhu L; Wang D; Luo Y; Shang Z; Xiao M; Mao X; Zhou K; Cao L; Dong L; Zheng X; Sui P; He J; Mo S; Yan J; Ao Q; Qiu L; Zhou H; Liu Q; Zhang H; Li J; Jin J; Fu L; Zhao W; Chen J; Du X; Qing G; Liu H; Liu X; Huang G; Ma D; Zhou J; Wang QF
Cell Res; 2018 Feb; 28(2):172-186. PubMed ID: 29148541
[TBL] [Abstract][Full Text] [Related]
40. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.
Zambello R; Falco M; Della Chiesa M; Trentin L; Carollo D; Castriconi R; Cannas G; Carlomagno S; Cabrelle A; Lamy T; Agostini C; Moretta A; Semenzato G; Vitale M
Blood; 2003 Sep; 102(5):1797-805. PubMed ID: 12750175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
